148 related articles for article (PubMed ID: 33299993)
1. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
Starr TN; Greaney AJ; Addetia A; Hannon WW; Choudhary MC; Dingens AS; Li JZ; Bloom JD
bioRxiv; 2020 Dec; ():. PubMed ID: 33299993
[TBL] [Abstract][Full Text] [Related]
2. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19.
Starr TN; Greaney AJ; Addetia A; Hannon WW; Choudhary MC; Dingens AS; Li JZ; Bloom JD
Science; 2021 Feb; 371(6531):850-854. PubMed ID: 33495308
[TBL] [Abstract][Full Text] [Related]
3. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.
Starr TN; Greaney AJ; Dingens AS; Bloom JD
bioRxiv; 2021 Feb; ():. PubMed ID: 33655250
[TBL] [Abstract][Full Text] [Related]
4. Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016.
Starr TN; Greaney AJ; Dingens AS; Bloom JD
Cell Rep Med; 2021 Apr; 2(4):100255. PubMed ID: 33842902
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants.
Yi C; Sun X; Lin Y; Gu C; Ding L; Lu X; Yang Z; Zhang Y; Ma L; Gu W; Qu A; Zhou X; Li X; Xu J; Ling Z; Xie Y; Lu H; Sun B
Genome Med; 2021 Oct; 13(1):164. PubMed ID: 34649620
[TBL] [Abstract][Full Text] [Related]
6. Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition.
Greaney AJ; Starr TN; Gilchuk P; Zost SJ; Binshtein E; Loes AN; Hilton SK; Huddleston J; Eguia R; Crawford KHD; Dingens AS; Nargi RS; Sutton RE; Suryadevara N; Rothlauf PW; Liu Z; Whelan SPJ; Carnahan RH; Crowe JE; Bloom JD
bioRxiv; 2020 Sep; ():. PubMed ID: 32935107
[TBL] [Abstract][Full Text] [Related]
7. Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity.
Nguyen H; Salkeld J; Agarwal S; Goodman A
Clin Infect Pract; 2021 Nov; 12():100089. PubMed ID: 34426799
[TBL] [Abstract][Full Text] [Related]
8. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
9. Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy.
Du S; Cao Y; Zhu Q; Yu P; Qi F; Wang G; Du X; Bao L; Deng W; Zhu H; Liu J; Nie J; Zheng Y; Liang H; Liu R; Gong S; Xu H; Yisimayi A; Lv Q; Wang B; He R; Han Y; Zhao W; Bai Y; Qu Y; Gao X; Ji C; Wang Q; Gao N; Huang W; Wang Y; Xie XS; Su XD; Xiao J; Qin C
Cell; 2020 Nov; 183(4):1013-1023.e13. PubMed ID: 32970990
[TBL] [Abstract][Full Text] [Related]
10. Comparative Perturbation-Based Modeling of the SARS-CoV-2 Spike Protein Binding with Host Receptor and Neutralizing Antibodies: Structurally Adaptable Allosteric Communication Hotspots Define Spike Sites Targeted by Global Circulating Mutations.
Verkhivker GM; Agajanian S; Oztas DY; Gupta G
Biochemistry; 2021 May; 60(19):1459-1484. PubMed ID: 33900725
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of neutralizing antibody cocktail in hemodialysis patients: a case series of 20 patients treated with or without REGN-COV2.
Arikawa S; Fukuoka K; Nakamoto K; Kunitomo R; Matsuno Y; Shimazaki T; Saraya T; Kawakami T; Kishimoto M; Komagata Y; Kurai D; Ishi H; Kaname S
Clin Exp Nephrol; 2022 May; 26(5):476-485. PubMed ID: 35182277
[TBL] [Abstract][Full Text] [Related]
12. Neutralizing monoclonal antibodies present new prospects to treat SARS-CoV-2 infections.
Lai R; Zhou T; Xiang X; Lu J; Xin H; Xie Q
Front Med; 2021 Aug; 15(4):644-648. PubMed ID: 33909259
[TBL] [Abstract][Full Text] [Related]
13. Clinical Effectiveness of REGN-COV2 in Patients with COVID-19 in Japan: A Retrospective Cohort Study with a Bayesian Inference.
Amano N; Iwata K; Iwata S
Infect Chemother; 2021 Dec; 53(4):767-775. PubMed ID: 34979607
[TBL] [Abstract][Full Text] [Related]
14. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JCC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
bioRxiv; 2020 Jul; ():. PubMed ID: 32743579
[TBL] [Abstract][Full Text] [Related]
15. Emergent Inpatient Administration of Casirivimab and Imdevimab Antibody Cocktail for the Treatment of COVID-19 Pneumonia.
Phan AT; Gukasyan J; Arabian S; Wang S; Neeki MM
Cureus; 2021 May; 13(5):e15280. PubMed ID: 34194882
[TBL] [Abstract][Full Text] [Related]
16. Neutralizing antibodies targeting the SARS-CoV-2 receptor binding domain isolated from a naïve human antibody library.
Bell BN; Powell AE; Rodriguez C; Cochran JR; Kim PS
Protein Sci; 2021 Apr; 30(4):716-727. PubMed ID: 33586288
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 receptor-binding mutations and antibody contact sites.
Mejdani M; Haddadi K; Pham C; Mahadevan R
Antib Ther; 2021 Jul; 4(3):149-158. PubMed ID: 34386694
[TBL] [Abstract][Full Text] [Related]
18. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
Front Immunol; 2021; 12():691715. PubMed ID: 34149735
[TBL] [Abstract][Full Text] [Related]
19. Complete mapping of viral escape from neutralizing antibodies.
Doud MB; Hensley SE; Bloom JD
PLoS Pathog; 2017 Mar; 13(3):e1006271. PubMed ID: 28288189
[TBL] [Abstract][Full Text] [Related]
20. Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen.
Jiang M; Zhang G; Liu H; Ding P; Liu Y; Tian Y; Wang Y; Wang A
Front Immunol; 2021; 12():707977. PubMed ID: 34621266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
